AstraZeneca AB Looks to Charles River Laboratories (Massachusetts) for in Vivo Biology
10/17/2012 9:00:52 AM
More...
|
AstraZeneca AB Release: Crestor Delivers Latest LDL-C Targets in High-Risk Patients at Lower Doses than Other Statins
3/27/2012 9:52:25 AM
More...
|
AstraZeneca AB Announces First Direct-to-Patient Program Offering the Brand ARIMIDEX® (anastrozole) Tablets to Patients for Only $40 Per Month
2/16/2012 8:13:17 AM
More...
|
Critical Diagnostics Release: ST2 Values Predict Mortality and Morbidity in Heart Failure Patients: Results from the AstraZeneca AB-sponsored CORONA Study
2/13/2012 7:43:33 AM
More...
|
National Association for Female Executives (NAFE) Release: AstraZeneca AB Recognized as a Top Company for Female Executives
2/7/2012 9:02:03 AM
More...
|
Q&A About $100 Million Asia, Emerging Markets Strategy With AstraZeneca AB's Head of R&D
2/3/2012 7:04:20 AM
More...
|
AstraZeneca AB Release: Fourth Quarter and Full Year Results 2011
2/2/2012 7:28:39 AM
More...
|
AstraZeneca AB May Shed Thousands More Jobs
1/30/2012 8:06:58 AM
More...
|
AstraZeneca AB Strikes New Deals Worth $140 Million With Hutchison China MediTech (Chi-Med) and Astellas Pharma US After R&D Setbacks
12/21/2011 7:53:45 AM
More...
|
AstraZeneca AB Slumps as Depression Drug Developed With AstraZeneca PLC (AZN) Misses Goal
12/20/2011 6:34:25 AM
More...
|
|